GILD.CI

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh · BCBA:GILD.CI

69,850.00 ARS−1,600.00 −2.24%

Gilead Sciences, Inc. Shs Cert Deposito Arg Repr 1/4 Sh (BCBA:GILD.CI) last traded at 69,850.00 ARS, down 2.24% on the day. Over the past year the stock is up 55.71%. Its 52-week range is 44,100.00 to 71,450.00. It is in the Health Technology sector (Biotechnology).

Key statistics

Open69,850.00

Day range69,850.00 – 69,850.00

52-week range44,100.00 – 71,450.00

Volume173

Average volume (10 days)31

Market cap (USD)211.64 B

EPS (TTM) (USD)−0.6871

Dividend yield1.04%

Beta (1 year)−0.0737

Revenue (TTM) (USD)29.35 B

Employees17.00 K

Performance

+7.88%1 week

+15.84%1 month

+34.98%3 months

+41.51%6 months

+48.87%Year to date

+55.71%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Gilead to Present Late-Breaking Clinical Data and Real-World Evidence at HIV GlasgowBusinessWire · 02 Nov 2026
Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?Stocktwits · 02 Nov 2026
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
Gilead Sciences Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
Gilead Sciences Is Maintained at Overweight by JP MorganDow Jones Newswires · 30 Oct 2026
Gilead Sciences Price Target Raised to $188.00/Share From $165.00 by CitigroupDow Jones Newswires · 30 Oct 2026
Gilead Sciences Is Maintained at Sector Outperform by ScotiabankDow Jones Newswires · 30 Oct 2026
Gilead Sciences to Present at Upcoming Fourth Quarter 2026 Investor ConferencesBusinessWire · 30 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.